Revenue segments as reported by the company.

Net revenue, before excise taxes

Excise taxes

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

Research and development

General and administrative

Restructuring costs

Share-based payments

Depreciation and amortization

Impairment loss on goodwill and indefinite-lived intangible assets

Impairment loss on long-lived assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cronos Group

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. The company was founded on August 21, 2012 and is headquartered in Toronto, Canada.

Curaleaf Holdings, Inc.

Curaleaf Holdings Inc. CURA, +15.80% responded late Friday to reports it was among those interested in buying Canadian cannabis company Cronos Inc. CRON, +6.91%. Curaleaf said the Canadian Investment Regulatory Organization had requested a comment on market speculation.

Curaleaf issues statement on reported interest in Cronos

Cronos Group Inc (NASDAQ:CRON, TSX:CRON) Thursday confirmed it is in talks with potential buyers interested in purchasing the Toronto-based global cannabinoid company, which includes US-based Curaleaf Holdings Inc, Reuters reported. Cronos, which is backed by cigarette maker Altria Group Inc, stated that it is in the initial stages of reviewing the indications of interest while cautioning there's no assurance that any agreement or transaction will result.

Cronos Group eyes company sale; Curaleaf a potential bidder

Curaleaf Holdings Inc. CURLF, +2.19% said Friday that it does not comment on market speculation after reports suggested it may be involved in a transaction. “The Company does not intend to make further comment unless required by law,” Curaleaf said in a statement.

Curaleaf says it does not comment on market speculation amid reports it may be interested in Cronos

Cronos Group Inc. CRON, -4.08% CRON, -3.83% stock is up nearly 6% in premarket trades on Friday after the Canadian cannabis company said it's reviewing unsolicited indications of interest from potential buyers. The company said it confirmed that it has received “a number” of inquiries about “a potential transaction involving Cronos.

Cronos Group stock rises in premarket as it confirms merger talks

A media report alleged that the marijuana company has put itself up for sale. Cronos soon confirmed this news.

Why Cronos Group Stock Tanked Today

TORONTO, July 06, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today confirmed that it has received a number of unsolicited indications of interest from third parties, each regarding a potential transaction involving Cronos and the third party. Cronos is in the initial stages of reviewing these indications of interest, and there can be no assurance that any agreement or transaction will result therefrom. Cronos does not intend to make any further announcements regarding this matter unless and until required to do so by applicable law.

Cronos Group Inc. confirms receipt of unsolicited indications of interest

Altria

Cronos Group Inc , the Canadian cannabis producer backed by cigarette maker Altria Group Inc , is exploring options that include a potential sale after attracting acquisition interest, according to people familiar with the matter.

Exclusive: Altria-backed cannabis producer Cronos explores sale -sources

SNDL Inc.

Village Farms International

Investing in marijuana stocks takes having a better understanding of how the sector and companies work. For example, when you can learn study, and know what a company has done and is currently doing it helps to make better investment choices. No one wants to invest in companies that had prior success but are struggling to see progress. Not to mention the industry is still young and new companies are being created. In addition to seasoned companies ethier creating strategic partnerships or being acquired.

3 Top Marijuana Stocks For Cannabis Investing July 2023

Bitfarms Ltd

Polestar Automotive Holding UK PLC

Most investors agree that a portfolio should have both blue-chip stocks and high-quality growth stocks. However, it's also necessary to have 10% to 15% of expose in your portfolio to high-risk high return stocks.

Chasing the Big Score: 3 Risky Stocks With the Potential for Mind-Blowing 10-Bagger Returns

Aurora Cannabis

Canopy Growth

Tilray Brands

Do you intend to invest in the top marijuana stocks for the long term? Given the market volatility associated with the best cannabis stocks to watch, it may be difficult to locate long-term investments that provide a general sense of stability. The cannabis market could more than double in the next five years. In the United States, the cannabis industry will also grow. Congress is currently working on SAFE Banking, which could lead to a new surge in marijuana stocks. Investors can profit from the market's momentum by capitalizing on the sector's revival.

Cannabis ETFs: A Strategic Approach to Long-Term Investing in the Rapidly Expanding Marijuana Sector

Green Thumb Industries Inc.

Trulieve Cannabis Corp.

A super PAC called Legalize America is launching Wednesday with backing from advocacy group the U.S. Cannabis Council and legal cannabis companies. It's described as the first super PAC aimed at cannabis reform in the U.S., MarketWatch has learned.

Customer donations at cannabis shops may help fund new super PAC called Legalize America

Cronos Group (NASDAQ: CRON) stock price has underperformed the market as the outlook of the cannabis industry worsens. The shares bottomed at $1.69 this year, which was over 93% below the highest level on record.

Cronos Group stock: Grossly overvalued as bottoming signs emerge

Borr Drilling Ltd

MakeMyTrip

There can be times where a fundamentally strong business faces financial headwinds. This can be in the form of margin contraction or revenue de-growth.

3 Turnaround Stocks to Buy for Massive Upside Potential

TORONTO, June 23, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announces that at its Annual Meeting of Shareholders held yesterday, June 22, 2023 (the “Meeting”), shareholders holding a total of 247,410,987 common shares of the Company voted in person or by proxy, representing 64.96% of the total number of common shares of the Company outstanding.

Cronos Group Inc. Announces Results of 2023 Annual Meeting of Shareholders

HEXO Corp

Over the past few years, the cannabis industry has experienced tremendous growth. Much of which is showing no signs of slowing down anytime soon. The industry has grown from being a niche market to a multi-billion dollar industry, with legal cannabis sales in North America alone projected to reach over $30 billion by 2025.

The Growth And Future Potential Of The Cannabis Industry

Hecla Mining

Kinross Gold

Solid Power

In general, the investment horizon is long term for blue-chip stocks or high-quality growth stocks. However, penny stocks are high risk and exposure is generally for a shorter time-frame.

7 Millionaire-Maker Penny Stocks to Buy And Hold Forever

On a relative basis, the interest in penny stocks has declined as compared to the euphoria of 2021. In challenging market conditions, investors are focused on blue-chip stocks and high-quality growth stocks.

Grab These 3 Massively Undervalued Penny Stocks Before They Soar

Diana Shipping

EVgo

Li-Cycle Holdings Corp

Lumen Technologies

Undervalued penny stocks to buy stand out as potential goldmines, ready to offer robust returns for audacious investors. Despite macroeconomic headwinds, the S&P 500 has shown resilience, trending higher by 13.8% year-to-date.

7 Very Undervalued Penny Stocks to Buy in June 2023

Neptune Wellness Solutions Inc.

One of the main reasons finding the best marijuana stocks to buy is a good investment is the potential for high growth. Even with its current increase in volatility and pullbacks the cannabis industry is expected to continue its growth as more states legalize cannabis. In addition, the demand for more cannabis products is expected to increase.

Top Marijuana Stocks To Invest In This Month

Nordic American Tankers

While the markets continue to face macroeconomic headwinds, I still believe that now is a great time to buy some of the most undervalued penny stocks and growth stocks. As an observation, the, the S&P 500 index has trended higher by 11% for year-to-date 2023.

The 7 Most Undervalued Penny Stocks to Buy in June 2023

Innovative Industrial Properties

As the societal tides turn, the once-stigmatized cannabis sphere has effectively emerged as a promising investment frontier. Amid the crescendo of acceptance from consumers and regulators alike, the sector is ripe with opportunities for savvy investors seeking high-potential cannabis stocks.

The 7 Best Cannabis Stocks to Buy for June 2023

OrganiGram Holdings Inc.

As the global cannabis sector gains traction, Canadian cannabis stocks remain at the vanguard, providing investors with attractive options in a quickly expanding market. The cannabis sector in Canada has grown dramatically, attracting investors from all walks of life. The country's forward-thinking approach to cannabis legalization, as well as its strong regulatory structure, have created a climate that encourages growth, innovation, and profitability. As a result, with companies at various phases of development and diversification, Canadian cannabis stocks have emerged as an interesting investment opportunity.

Top Canadian Penny Stocks To Buy? 3 To Watch

Within the penny stock space, the level of risk on exposure to different stocks varies significantly. Purely speculative penny stocks are the riskiest bet.

3 High-Reward Penny Stocks for Bold Investors

Cronos Group Inc (NASDAQ:CRON, TSX:CRON) said it has decided to streamline its operating structure by winding down and exiting its existing US hemp-derived CBD-focused operations by the end of the second quarter of 2023. The global cannabinoid company noted it made the move to improve its cash flow in the near term and position itself to directly enter the US THC market when the necessary changes in the country's regulatory conditions occur.

Cronos Group exits US hemp CBD business to boost cash flow

Cronos Group, Tilray Brands, and Canopy Growth were all popular marijuana stocks in 2018. Investors who would've held on to those investments over the past five years would be down between 74% and 97%.

3 Awful Stock Returns That Highlight the Cannabis Industry's Struggles Since 2018

News for Cronos Group Stock (CRON)